| Literature DB >> 30397348 |
Toszka Bohn1, Steffen Rapp2, Natascha Luther3, Matthias Klein1, Till-Julius Bruehl1, Nobuhiko Kojima4, Pamela Aranda Lopez5, Jennifer Hahlbrock1, Sabine Muth1, Shogo Endo6, Stefanie Pektor7, Almut Brand8, Kathrin Renner8,9, Vanessa Popp10, Katharina Gerlach10, Dennis Vogel11, Christina Lueckel1,11, Danielle Arnold-Schild1, Jacques Pouyssegur12,13, Marina Kreutz8,9, Magdalena Huber11, Jochem Koenig14, Benno Weigmann10, Hans-Christian Probst1,15, Esther von Stebut16, Christian Becker3,15, Hansjoerg Schild1,15,17, Edgar Schmitt1,15, Tobias Bopp18,19,20,21.
Abstract
Many tumors evolve sophisticated strategies to evade the immune system, and these represent major obstacles for efficient antitumor immune responses. Here we explored a molecular mechanism of metabolic communication deployed by highly glycolytic tumors for immunoevasion. In contrast to colon adenocarcinomas, melanomas showed comparatively high glycolytic activity, which resulted in high acidification of the tumor microenvironment. This tumor acidosis induced Gprotein-coupled receptor-dependent expression of the transcriptional repressor ICER in tumor-associated macrophages that led to their functional polarization toward a non-inflammatory phenotype and promoted tumor growth. Collectively, our findings identify a molecular mechanism of metabolic communication between non-lymphoid tissue and the immune system that was exploited by high-glycolytic-rate tumors for evasion of the immune system.Entities:
Mesh:
Year: 2018 PMID: 30397348 DOI: 10.1038/s41590-018-0226-8
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606